28 August 2025
28 August 2025
Moderna and Pfizer/BioNTech have secured formula updates to existing mRNA Covid-19 vaccines.
Safeguards against the appearance of AI consciousness are needed to protect against 'AI psychosis', says Dr. Hamilton Morrin.
AMX0035 failed to show a difference to placebo in the Phase IIb ORION trial.
Zemcelpro targets adults with haematological malignancies needing allogeneic stem cell transplants.
Eli Lilly experienced the highest revenue growth of 32% to $45bn, followed by Novo Nordisk with 25.5% growth to $42.1bn.
The status was granted following the top-line outcomes of a Phase II trial carried out in 2023 and 2024.
Part of $1 billion investment strategy, PCI Pharma Services completes acquisition of Ajinomoto Althea, enhancing US drug product manufacturing for aseptic filling of prefilled syringes & cartridges.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
